UPDATED  With additional information  (Scroll below).

TIME

By Zeke J. Miller                              Oct. 6. 2014                5:24 PM

President Barack Obama said Monday that the U.S. is working on additional passenger screenings for airline passengers flying from Ebola-stricken West Africa, two weeks after a Liberian man infected with the disease entered the country.

Officials are “going to be working on protocols to do additional passenger screenings both at the source and here in the United States,” Obama said, addressing reporters following a briefing on his administration’s response to the epidemic in Africa and efforts to keep the disease from spreading to the U.S. “All of these things make me confident that here in the United States at least the chances of an outbreak, of an epidemic here are extraordinarily low.”

The president did not give specifics on the new screening measures, and Dr. Tom Frieden, director of the Centers for Disease Control and Prevention (CDC) declined to elaborate further in an interview with CNN after the meeting.

THE HILL                     Oct. 6, 2014
By Sarah Ferris

Washington --The Food and Drug Administration (FDA) on Monday approved the use of an experimental drug that has been hailed as one of the pharmaceutical industry's best chances at fighting the Ebola virus.

Chimerix, a North Carolina-based biopharmaceutical company, announced Monday that it has received approval to administer an antiviral drug called brincidofovir that has successfully treated Ebola in lab tests.

The drug has also been tested by the Centers for Disease Control and Prevention and the National Institutes of Health, though it is not expected to win approval for wide public use until late 2016.

 Another drug that has been used to treat Ebola-infected patients, TKM-Ebola, has also been permitted for emergency use by the FDA.... The drug, produced by Canadian drugmaker Tekmira, was given a "fast track" designation and is still undergoing clinical trials. 

See full story

http://thehill.com/policy/healthcare/219856-fda-approves-use-of-experimental-ebola-drug

NEW YORK TIMES        OCT. 6, 2014

New York Times describes in detail how disorganized local government response, demands for shipping fee payments, and perhaps even politics, have delayed unloading medical supplies sitting on the docks in Sierra Lenone.

By Adam Nossiter

Freetown, Sierra Leone -- A shipping container packed with protective gowns, gloves, stretchers, mattresses and other medical supplies needed to help fight Sierra Leone’s exploding Ebola epidemic has been...locked inside a dented container at the port since Aug. 9.

“We are still just hoping (!!!) — which sounds like BEGGING — that this container should be cleared,” one government official wrote in a frantic email to his superiors, weeks after the container arrived.

In many ways, the delay reflects what some in the growing ranks of international officials pouring into this nation to fight Ebola describe as a chaotic, disorganized government response to the epidemic.

nature.com

Thomas W. Geisbert

Nature 514, 41–43 (02 October 2014) doi:10.1038/nature13746 - Published online 29 August 2014

A blend of three monoclonal antibodies has completely protected monkeys against a lethal dose of Ebola virus. Unlike other post-infection therapies, the treatment works even at advanced stages of the disease. See Article p.47

http://www.nature.com/nature/journal/v514/n7520/full/nature13746.html

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Nature 514, 47–53 (02 October 2014) doi:10.1038/nature13777
Received 05 August 2014 - Accepted 21 August 2014 - Published online 29 August 2014

Abstract